Akoya Biosciences Inc
12 articles with Akoya Biosciences Inc
Akoya Biosciences, Inc., The Spatial Biology Company®, today announced that the company received ISO 13485:2016 certification for the design, development, production, distribution and installation of medical devices and related services. Achieving this ISO certification s
Akoya Biosciences Unveils New Spatial Biology Platform to Enable Rapid Image Analysis and Secure Data Sharing
Akoya Biosciences, Inc., The Spatial Biology Company™, today announced the availability of Proxima™, The Spatial Biology Platform™ to integrate rapid image acquisition and secure data sharing in the cloud with immediate access from anywhere for geographically distributed and remote teams, including those working from home during the COVID-19 pandemic.
9/4/2020Biopharma and life science companies from across the globe strengthen their leadership teams and boards with these Movers & Shakers.
Akoya Biosciences, Inc., The Spatial Biology Company™, today announced the expansion of its leadership team with the appointment of two senior leaders with expertise in spatial biology and molecular pathology.
Landmark Cell Publication Reveals Novel Spatial Biology Discoveries Enabled by the CODEX® Platform New peer-reviewed paper outlines novel organizing principles and spatial interactions between “neighborhoods” of cells in the tumor microenvironment of colorectal cancer. MENLO PARK, Calif.--( BUSINESS WIRE )-- Akoya Biosciences, Inc., The Spatial Biology Company™, today announced the application of the CODEX® platform to a recent Cell publication ti
Akoya Biosciences Collaborates with Leading Cancer Center to Discover Predictive Biomarkers for Cancer
University of California San Francisco (UCSF) uses Phenoptics™ platform to help with biomarker discovery Akoya, UCSF and the I-SPY TRIAL consortium collaborate to discover and validate biomarker signatures for predicting response to neoadjuvant and adjuvant immunotherapies MENLO PARK, Calif.--( BUSINESS WIRE )-- Akoya Biosciences, Inc., The Spatial Biology Company™, today announced a collaboration with UCSF Helen Diller Family Comprehe
Akoya Biosciences, Inc., The Spatial Biology Company™, today announced the completion of a $50 million financing from both new and existing investors.
Akoya Expands Spatial Biology Portfolio with Optimized PD-1/PD-L1 Panels for Melanoma and Lung Cancer
Akoya Biosciences, Inc., The Spatial Biology Company™, announced that it has launched two new multiplex immunofluorescence kits, expanding its portfolio of solutions for profiling immuno-oncology biomarkers in the tumor microenvironment.
Precision for Medicine and Akoya Partner to Develop Advanced Liquid Biopsy and Tissue Biomarker Tests
Circulating tumor cells (CTCs) have long been known to exist in cancer patients’ blood.
Akoya Biosciences, Inc., The Spatial Biology Company™, announced today that an in-depth comparison of immuno-oncology biomarker types conducted by scientists at Johns Hopkins University, Yale University, and other institutions
Akoya Biosciences’ Multiplex Immunofluorescence Technology for Cancer Research to be Featured at AACR 2019
Company to present data sets from recently launched high-parameter, spatial biology imaging platforms for discovery through clinical and translational research
Commercial launch of CODEX® System and Phenoptics™ 2.0 provide the most complete suite of tools for tissue biomarker discovery and translation